- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Top 5 AJMC® Articles of September 2018
Here are the top 5 articles for the month of September.
Transcript:
Hi, I’m Jaime Rosenberg for The American Journal of Managed Care®. Here are the top 5 articles for the month of September.
Number 5: An analysis from the Urban Institute found that health insurance coverage gains created by the Affordable Care Act caused the number of uninsured Americans to fall from 17% in 2013 to 10% in 2016.
Number 4: More than half of Americans misused prescription drugs in 2017. While the rate remains unchanged from 2016, there was an observed shift from prescription opioids to other drugs and dangerous drug combinations
Number 3: GlaxoSmithKline’s mepolizumab, marketed as Nucala, is superior to reslizumab and benralizumab for the treatment of eosinophilic asthma, a severe form of asthma that doesn’t respond well to corticosteroids, even at high doses.
Number 2: Researchers have discovered a new subtype of multiple sclerosis that has neuronal loss but no demyelination of the brain’s white matter, suggesting that demyelination and neuronal degeneration occur independently.
Number 1: A study looking at the toxic effects of cancer immunotherapy concluded that the incidence and timing of rare and fatal side effects from immune checkpoint inhibitors remain very low for patients with advanced cancer and should not keep patients from using the therapies.
To read all of these articles and more, visit AJMC.com
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Gene and Cell Therapies Hold Potential—but How Can Payers Manage Their Costs?
April 18th 2024Presenters at the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting discussed the current promise and future potential of gene and cell therapies, as well as payer management strategies for these costly treatments.
Read More
Commonwealth Fund Report Details Pervasive Racial and Ethnic Disparities in US Health Care, Outcomes
April 18th 2024Using 25 health system performance indicators, the Commonwealth Fund 2024 State Health Disparities Report evaluated racial and ethnic disparities in health care and health outcomes both within and across US states and highlighted the urgent need for equitable health care policies and practices in the US.
Read More
